| Característica |
Objectiu de la convocatòria
This competitive program seeks provide educational grants to
support continuing education projects focused on the evolving
treatment landscape for patients with relapsed/refractory multiple
myeloma (RRMM).
|
Característiques principals
Applicants are encouraged to identify and address the educational
needs, barriers, and gaps related to the care of patients with RRMM
and the use of bispecific antibody therapies. Proposed activities
should focus on increasing clinicians’ knowledge, confidence,
competence and practice changes in caring for patients with RRMM.
This may include interactive learning, case-based learning,
workshops, tumor boards, digital platforms, visiting professors,
mentorships, building communities of practice, symposia and other
live programs.
|
Lloc de presentació
IMIM and PSMAR staff who need more information should contact::
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: cbarnwell@imim.es Ext.: 1670
Marta López: mlopez4@imim.es Ext.: 1576
|
Convocatòria (URL)
https://cdn.pfizer.com/pfizercom/2023-11/GMG_2024-ONC-G_AddressingGapsMMIME.pdf?VersionId=MKMbvY5J74A99cofQjR23PIC2SsJvaWY
|
Requisits
Only organizations are eligible to receive grants, not individuals or medical practice groups.
The following may apply: medical, nursing, allied health, and/or pharmacy professional schools;
healthcare institutions (both large and small); non-profit professional organizations/medical societies
and other non-profit entities with a mission related to healthcare professional education and/or
healthcare improvement. Medical education companies and for-profit organizations are welcome to
submit, however non-profit professional organizations/medical societies and medical
schools/institution will be prioritized.
If the project involves multiple departments within an institution and/or between different institutions /
organizations / associations. All institutions must have a relevant role and the requesting organization
must have a key role in the project.
The applicant must be the project/program lead or an authorized designee of such individual (e.g.,
project/program lead’s grant coordinator).
The project/program lead must be an employee or independent contractor of the requesting
organization.
Requesting organization must be legally able to receive award funding directly from Pfizer Inc. We
strongly recommend that applicants confirm this with their organization or institution prior to submitting
an application. Grants awarded to organizations that are subsequently found to be unable to accept
funding directly from Pfizer Inc. may be subject to rescission.
For projects offering continuing education credit, the requesting organization must be accredited
|
Dotació
Up to $200,000
|
Durada
12 to 15 months
|
AVÍS IMPORTANT
Anticipated decision notification date: February 5, 2024
Anticipated project start date: April 2024
|